Adagene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.About ADAG
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.
CEOPei Zhi Luo
CEOPei Zhi Luo
Employees138
Employees138
HeadquartersSuzhou, Jiangsu
HeadquartersSuzhou, Jiangsu
Founded2011
Founded2011
Employees138
Employees138
ADAG Key Statistics
Market cap87.14M
Market cap87.14M
Price-Earnings ratio-2.97
Price-Earnings ratio-2.97
Dividend yield—
Dividend yield—
Average volume82.65K
Average volume82.65K
High today$1.99
High today$1.99
Low today$1.83
Low today$1.83
Open price$1.96
Open price$1.96
Volume84.34K
Volume84.34K
52 Week high$3.16
52 Week high$3.16
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
As of today, Adagene(ADAG) shares are valued at $1.85. The company's market cap stands at 87.14M, with a P/E ratio of -2.97.
During the trading session on 2025-12-10, Adagene(ADAG) shares reached a daily high of $1.99 and a low of $1.83. At a current price of $1.85, the stock is +0.6% higher than the low and still -7.3% under the high.
Trading volume for Adagene(ADAG) stock has reached 84.34K, versus its average volume of 82.65K.
The stock's 52-week range extends from a low of $1.30 to a high of $3.16.
The stock's 52-week range extends from a low of $1.30 to a high of $3.16.